Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Bioorg Med Chem. 2011 Apr 24;19(11):3347–3356. doi: 10.1016/j.bmc.2011.04.042

Table 4.

PAT CoMFA Model.

Model q2a SEPb Comp.c r2d SEE e Steric Electrostatic
15 0.352 0.431 3 0.818 0.229 0.618 0.382
2 0.270 0.449 4 0.852 0.202 0.549 0.451
3 0.345 0.428 3 0.809 0.231 0.607 0.393
4 0.246 0.475 4 0.831 0.225 0.597 0.403
5 0.423 0.429 5 0.878 0.197 0.552 0.448
6 0.313 0.463 6 0.893 0.182 0.510 0.490

Footnotes: Models 1–6 were constructed as described in the text and the compounds in each set are listed in the Supplementary data.

a

q2 is the cross validated r2 derived from Leave-One-Out SAMPLS (LOO SAMPLS) cross validation analysis as implemented in SYBYL8.2.

b

SEP is the Standard Error of Prediction reported for the LOO SAMPLS analysis.

c

Comp. is the number of components used in the model;

d

r2, non-cross-validated correlation coefficient.

e

SEE is the Standard Error of Estimate derived from the Non-Validated analysis.